1. Home
  2. TTC vs GKOS Comparison

TTC vs GKOS Comparison

Compare TTC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$102.79

Market Cap

8.8B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$174.80

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
GKOS
Founded
1914
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Tools/Hardware
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.7B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
TTC
GKOS
Price
$102.79
$174.80
Analyst Decision
Buy
Strong Buy
Analyst Count
6
14
Target Price
$111.00
★ $199.31
AVG Volume (30 Days)
561.2K
★ 884.0K
Earning Date
09-03-2026
10-28-2026
Dividend Yield
★ 1.55%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.99
N/A
Revenue
★ $2,618,650,000.00
$507,442,000.00
Revenue This Year
$6.31
$36.30
Revenue Next Year
$4.19
$23.25
P/E Ratio
$33.48
★ N/A
Revenue Growth
4.53
★ 32.33
52 Week Low
$67.64
$73.16
52 Week High
$105.19
$191.62

Technical Indicators

Market Signals
Indicator
TTC
GKOS
Relative Strength Index (RSI) 61.44 51.74
Support Level $91.34 $147.72
Resistance Level $100.91 $186.99
Average True Range (ATR) 1.96 7.25
MACD 0.36 0.82
Stochastic Oscillator 63.06 74.55

Price Performance

Historical Comparison
TTC
GKOS

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: